Expertise in
17
conditions

Dr. Orwa Aboud

Neurology
UC Davis Comprehensive Cancer Center
2279 45th St, 
Sacramento, CA 
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth
Expertise in
17
conditions
UC Davis Comprehensive Cancer Center
2279 45th St, 
Sacramento, CA 

Overview

Orwa Aboud is a Neurologist practicing medicine in Sacramento, California.

Dr. Aboud is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Astrocytoma, Glioma, Glioblastoma, and Brain Tumor.

He is actively involved in clinical research, co-authoring 59 peer reviewed articles and participating in 4 clinical trials.

Specialties

Neurology

Licenses

Psychiatry & Neurology in MD

Hospital Affiliations

Sutter Amador Hospital
University Of California Davis Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

UC Davis Comprehensive Cancer Center
2279 45th St, Sacramento, CA 95817

Additional Areas of Focus

Dr. Aboud has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Phase II Trial of SMO/ AKT/ NF2/CDK Inhibitors in Progressive Meningiomas With SMO/ AKT/ NF2/CDK Pathway Mutations
Phase II Trial of SMO/ AKT/ NF2/CDK Inhibitors in Progressive Meningiomas With SMO/ AKT/ NF2/CDK Pathway Mutations
Enrollment Status: Recruiting
Publish Date: September 02, 2026
Intervention Type: Drug
Study Drugs: Vismodegib, GSK2256098, Capivasertib, Abemaciclib
Study Phase: Phase 2
A Randomized Phase II/III Open-Label Study of Ipilimumab and Nivolumab Versus Temozolomide in Patients With Newly Diagnosed MGMT (Tumor O-6-Methylguanine DNA Methyltransferase) Unmethylated Glioblastoma
A Randomized Phase II/III Open-Label Study of Ipilimumab and Nivolumab Versus Temozolomide in Patients With Newly Diagnosed MGMT (Tumor O-6-Methylguanine DNA Methyltransferase) Unmethylated Glioblastoma
Enrollment Status: Completed
Publish Date: April 22, 2026
Intervention Type: Other, Biological, Procedure, Drug, Radiation, Device
Study Drugs: Ipilimumab, Nivolumab, Temozolomide
Study Phase: Phase 2/Phase 3
Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma
Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma
Enrollment Status: Active_not_recruiting
Publish Date: January 22, 2026
Intervention Type: Drug, Radiation
Study Drugs: Concomitant Temozolomide (TMZ), Procarbazine, Adjuvant Temozolomide (TMZ), CCNU, Vincristine
Study Phase: Phase 3
Incidence of Intracranial Hemorrhage in Glioma Patients With Venous Thromboembolism Converted From LMWH to Apixaban
Incidence of Intracranial Hemorrhage in Glioma Patients With Venous Thromboembolism Converted From LMWH to Apixaban
Enrollment Status: Terminated
Publish Date: December 02, 2022
Intervention Type: Other
View 3 Less Clinical Trials

59 Total Publications

Metabolomic and lipidomic profiling reveals distinct subtypes of glioblastoma IDH-wildtype and shared metabolic features with astrocytoma IDH-mutant grade 4.
Metabolomic and lipidomic profiling reveals distinct subtypes of glioblastoma IDH-wildtype and shared metabolic features with astrocytoma IDH-mutant grade 4.
Journal: Neuro-oncology advances
Published: June 17, 2026
Similar Doctors
Expertise in
44
conditions
Expertise in
44
conditions
Referral may be required

Midtown Neurology Clinic

3160 Folsom Blvd Ste 2100, 
Sacramento, CA 
 (1.2 miles away)
916-734-3588
Languages Spoken:
English
See accepted insurances

Vicki Wheelock is a Neurologist practicing medicine in Sacramento, California. Dr. Wheelock is highly rated in 44 conditions, according to our data. Her clinical expertise encompasses Huntington Disease, Mcleod Neuroacanthocytosis Syndrome, Movement Disorders, and Hereditary Ataxia.

Expertise in
14
conditions
Expertise in
14
conditions
Referral may be required

UC Davis Neurosciences Clinic

3160 Folsom Blvd Ste 2100, 
Sacramento, CA 
 (1.2 miles away)
916-734-3588
Experience:
44+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Charles Decarli is a Neurologist practicing medicine in Sacramento, California. He has been practicing medicine for over 44 years. Dr. Decarli is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Dementia, Alzheimer's Disease, Stroke, and CACH Syndrome.

Expertise in
22
conditions
Dr. Lin Zhang
Neurology
Expertise in
22
conditions
Dr. Lin Zhang
Neurology
Referral may be required
Before you request

UC Davis Neurosciences Clinic

3160 Folsom Blvd Ste 2100, 
Sacramento, CA 
 (1.2 miles away)
916-734-3588
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Lin Zhang is a Neurologist practicing medicine in Sacramento, California. Dr. Zhang is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Drug Induced Dyskinesia, Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency, Familial Paroxysmal Nonkinesigenic Dyskinesia, and Dopa-Responsive Dystonia. Dr. Zhang is currently accepting new patients.

Frequently Asked Questions about Dr. Orwa Aboud

How do I make an appointment with Dr. Orwa Aboud?

You can book an appointment with Dr. Orwa Aboud by calling their office at 916-734-5959. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Orwa Aboud a top-rated expert for Astrocytoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Orwa Aboud is classified as an Elite expert for Astrocytoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Orwa Aboud specialize in?

While Dr. Orwa Aboud is a Neurology, they have specific expertise in Astrocytoma, Glioma, and Glioblastoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurology.

Does Dr. Orwa Aboud participate in research or clinical trials?

Yes. Dr. Orwa Aboud has published 59 articles and abstracts on conditions like Astrocytoma. You can view a list of Dr. Orwa Aboud's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Orwa Aboud accept my insurance?

Dr. Orwa Aboud accepts most major insurance plans, including Alignment Health Plan and Anthem BCBS. We recommend calling the office directly at 916-734-5959 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Aboud's expertise for a condition
ConditionClose
View All 10 Distinguished Conditions
View All 19 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile